Navigation Links
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Date:12/10/2008

KENILWORTH, N.J., Dec. 10 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Feb. 27, 2009, to shareholders of record at the close of business on Feb. 6, 2009. As of Sept. 30, 2008, there were 1,626,234,628 common shares outstanding.

The Board of Directors today also declared a quarterly dividend of $3.75 per share on the 2007 Mandatory Convertible Preferred Stock. Payment will be made on Feb. 16, 2009, to holders of record at the close of business on Feb. 2, 2009. There are currently 10 million shares of 2007 Mandatory Convertible Preferred Stock outstanding.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today
2. Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
3. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
4. Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
5. Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
6. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
7. Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
8. Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
9. Schering-Plough CEO Buys $2 Million in Common Shares
10. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
11. Schering-Plough Reports Financial Results for First Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/24/2014)... SILVER SPRING, Md. , Dec. 24, 2014  United ... that Medtronic, Inc. (NYSE: MDT ) has ... and Drug Administration (FDA) for the use of Medtronic,s ... a newly developed catheter) for use with United Therapeutics, ...
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. ... marketer of proprietary clinical grade hypothermic storage and ... products for cells and tissues  ("BioLife" or the "Company"), ... of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... Earlier this year in a June 24 ... Adult Stem Cell Technology Center, LLC ( ASCTC ) focused ... of adult tissue stem cells. His title “Asymmetric Self-Renewal ... the Future,” embodied the essence of his message to congress ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Acquisition Adds Late Stage Product Targeting Life-threatening Hereditary ... - Company to Host Conference Call at 10:30 A.M. Eastern Today ... ... 15 ViroPharma Incorporated,(Nasdaq: VPHM ) and Lev Pharmaceuticals, Inc. (OTC ...
... Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the,Company"), ... manufacture,research, development, marketing and distribution of probiotics ... Transfer & Trust Company,("AST") as its new ... 2008.,AST, headquartered in New York, New York, ...
... CryoLife, Inc. (NYSE: CRY ),a biomaterials, medical ... 2008 financial results will be released on,Thursday, July 31, ... webcast at 10:00 a.m. Eastern Time, July 31, 2008, ... session hosted by Steven G.,Anderson, president and CEO of ...
Cached Biology Technology:ViroPharma To Acquire Lev Pharmaceuticals 2ViroPharma To Acquire Lev Pharmaceuticals 3ViroPharma To Acquire Lev Pharmaceuticals 4ViroPharma To Acquire Lev Pharmaceuticals 5ViroPharma To Acquire Lev Pharmaceuticals 6ViroPharma To Acquire Lev Pharmaceuticals 7ViroPharma To Acquire Lev Pharmaceuticals 8ViroPharma To Acquire Lev Pharmaceuticals 9China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008 2CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2008 Financial Results 2
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced today ... to confirm its adherence to current U.S. Food and ... conduct regulated smart device and smart phone application trials ... quality. "HITLAB is determined to improve global ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Commemorate JPMorgan Chase & Co. , Foundation Funding of ... , , ... Franklin McKinley School District and Bring Me A Book (BMAB) ... San Jose Elementary School Library Initiative in Franklin McKinley School District.  The ...
... the University of California, Riverside Norman Ellstrand ... been awarded 2010 Guggenheim Fellowships by the John ... appointed on the basis of achievement and exceptional promise. ... genetics, genomics, and the many faces of hybridization. Herrera, ...
... The U.S. Environmental Protection Agency today awarded more than ... the country who participated in the 6th Annual National ... D.C. The P3 award competition and National Sustainable ... of Earth Day, April 23-26. Winners of the EPA,s ...
Cached Biology News:JPMorgan Chase & Co., Invests $25,000 to Support Bring Me A Book's San Jose Elementary School Library Initiative 2JPMorgan Chase & Co., Invests $25,000 to Support Bring Me A Book's San Jose Elementary School Library Initiative 32 professors at UC Riverside receive Guggenheim Fellowships 22 professors at UC Riverside receive Guggenheim Fellowships 3EPA awards more than $1 million to college teams for environmental innovation 2
VEGF Receptor-2, phospho-specific (Tyr996)...
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
IC50: 35 ng/ml · Limit of detection: 8 ng/ml...
Biology Products: